View in EDS HTML Full Text PDF Full Text

Population pharmacokinetic modeling of asciminib in support of exposure-response and ethnic sensitivity analyses in patients with chronic myeloid leukemia.

Saved in:
Bibliographic Details
Title: Population pharmacokinetic modeling of asciminib in support of exposure-response and ethnic sensitivity analyses in patients with chronic myeloid leukemia.
Authors: Darstein C; Novartis Pharma AG, Basel, Switzerland., Yoon D; Novartis Pharmaceuticals Corporation, Cambridge, MA, USA., Yang Y; Novartis Pharmaceuticals Corporation, Cambridge, MA, USA., Kapoor S; Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, New Jersey, 07936-1080, USA., Dasgupta K; Novartis Healthcare Private Ltd, Hyderabad, India., Wu S; Novartis Institutes for BioMedical Research Co. Ltd, Shanghai, China., Kawakita Y; Novartis Pharma K.K, Tokyo, Japan., Hoch M; Novartis Pharma AG, Basel, Switzerland., Grosch K; Novartis Pharma AG, Basel, Switzerland., Sy SKB; Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, New Jersey, 07936-1080, USA. sherwin.sy@novartis.com.
Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2025 Feb 28; Vol. 95 (1), pp. 39. Date of Electronic Publication: 2025 Feb 28.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40019625
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Population pharmacokinetic modeling of asciminib in support of exposure-response and ethnic sensitivity analyses in patients with chronic myeloid leukemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Darstein+C%22">Darstein C</searchLink>; Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Yoon+D%22">Yoon D</searchLink>; Novartis Pharmaceuticals Corporation, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Yang+Y%22">Yang Y</searchLink>; Novartis Pharmaceuticals Corporation, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Kapoor+S%22">Kapoor S</searchLink>; Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, New Jersey, 07936-1080, USA.<br /><searchLink fieldCode="AU" term="%22Dasgupta+K%22">Dasgupta K</searchLink>; Novartis Healthcare Private Ltd, Hyderabad, India.<br /><searchLink fieldCode="AU" term="%22Wu+S%22">Wu S</searchLink>; Novartis Institutes for BioMedical Research Co. Ltd, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Kawakita+Y%22">Kawakita Y</searchLink>; Novartis Pharma K.K, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hoch+M%22">Hoch M</searchLink>; Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Grosch+K%22">Grosch K</searchLink>; Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Sy+SKB%22">Sy SKB</searchLink>; Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, New Jersey, 07936-1080, USA. sherwin.sy@novartis.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227806519%22">Cancer chemotherapy and pharmacology</searchLink> [Cancer Chemother Pharmacol] 2025 Feb 28; Vol. 95 (1), pp. 39. <i>Date of Electronic Publication: </i>2025 Feb 28.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>7806519 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0843 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203445704%22">03445704 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Chemother Pharmacol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40019625
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00280-025-04755-y
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 39
    Titles:
      – TitleFull: Population pharmacokinetic modeling of asciminib in support of exposure-response and ethnic sensitivity analyses in patients with chronic myeloid leukemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Darstein C
      – PersonEntity:
          Name:
            NameFull: Yoon D
      – PersonEntity:
          Name:
            NameFull: Yang Y
      – PersonEntity:
          Name:
            NameFull: Kapoor S
      – PersonEntity:
          Name:
            NameFull: Dasgupta K
      – PersonEntity:
          Name:
            NameFull: Wu S
      – PersonEntity:
          Name:
            NameFull: Kawakita Y
      – PersonEntity:
          Name:
            NameFull: Hoch M
      – PersonEntity:
          Name:
            NameFull: Grosch K
      – PersonEntity:
          Name:
            NameFull: Sy SKB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 28
              M: 02
              Text: 2025 Feb 28
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1432-0843
          Numbering:
            – Type: volume
              Value: 95
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Cancer chemotherapy and pharmacology
              Type: main
ResultId 1